一个罕见的儿科病例的平色素与头皮的参与
Filomena Barbato1, Gaetano Licata2, Luca Damiani3
1Department of Pediatric Dermatology, Santobono-Pausilipon Children Hospital, Naples.
Dermatology reports
|January 23, 2026
概括
平色素 (LPP) 在儿童中很少见. 本病例报告描述了儿童患者头皮上LPP的第一个实例,扩大了这种罕见的皮肤疾病的已知的临床变异.
科学领域:
- 皮肤病学 皮肤病学
- 儿科皮肤病学 儿科皮肤病学
- 罕见疾病 罕见疾病
背景情况:
- 平色素 (LPP) 是一种罕见的慢性炎症性皮肤疾病.
- 主要影响印度次大陆和中东的成年人.
- 儿科LPP病例非常罕见,没有先前报告的头皮参与.
研究的目的:
- 为了呈现一个罕见的儿科平色素菌病例.
- 记录第一个报告的LPP影响头皮的儿童病例.
- 扩大对儿科患者中LPP临床谱的理解.
主要方法:
- 案例报告. 情况报告.
- 临床表现描述.
- 关于儿科LPP的现有文献的综述.
主要成果:
- 介绍了一例涉及头皮的儿科平色素的独特病例.
- 这一案例突出了儿童中LPP不具特征的临床表现.
- 这些发现有助于儿童LPP的有限知识基础.
结论:
- 儿科李氏平面色素菌可以在头皮上表现出来.
- 这个病例扩大了已知的儿童LPP的临床谱.
- 需要进一步的研究,以更好地了解儿童LPP.
相关概念视频
Antigens Involved in Adaptive Immunity
1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution
271
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
271
Pharmacokinetics in Pediatric Patients: Drug Metabolism
199
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
199
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
260
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
Ecological Succession
21.4K
Ecological succession is influenced by the processes of facilitation, inhibition, and toleration. Facilitation occurs when early successional species create more favorable ecological conditions for subsequent species, such as enhanced nutrient, water, or light availability. In contrast, inhibition happens when early successional species create unfavorable ecological conditions for potential successive species, such as limiting resource availability. In some cases, later successional species...
21.4K


